Rehovot, Israel

Tamar Danon

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Kfar Uriah-Doar-Na Shimshon, IL (2012)
  • Rehovot, IL (2009 - 2018)

Company Filing History:


Years Active: 2009-2018

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Tamar Danon: Innovator in Antibody Research

Introduction

Tamar Danon is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and pharmaceutical compositions. With a total of 8 patents to his name, Danon is recognized for his innovative approaches to inhibiting metalloproteins.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins." This patent describes an antibody that comprises an antigen recognition region featuring CDR amino acid sequences set forth in SEQ ID NO: 7, 8, 9, 10, 11, and 12. This invention holds promise for advancing therapeutic strategies in various medical applications.

Career Highlights

Tamar Danon is affiliated with Yeda Research and Development Co. Ltd., where he continues to push the boundaries of scientific research. His work has garnered attention for its potential impact on healthcare and disease treatment.

Collaborations

Danon has collaborated with notable colleagues, including Irit Sagi and Netta Sela, who have contributed to his research endeavors. Their combined expertise enhances the innovative capacity of their projects.

Conclusion

Tamar Danon stands out as a key figure in antibody research, with a strong portfolio of patents that reflect his dedication to innovation. His contributions are paving the way for advancements in medical science and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…